| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-09 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.25 | 8e-06 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.24 | 8e-05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.22 | 9e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |